Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
Biomedical Engineering Online|November 14, 2018
Objective and automatic classification of Parkinson disease with Leap Motion controllerA H Butt, E Rovini, C Dolciotti, et al.
Kidney International. Supplement|January 1, 1993
Cytokine mRNA expression by cultured rat mesangial cells after contact with environmental lectinsA Amore, F Cavallo, E Bocchietto, et al.
Gynecologic and Obstetric Investigation|November 23, 2011
Spatial analysis of the distribution of endometriosis in northwestern ItalyG Migliaretti, F Deltetto, E M Delpiano, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|March 16, 2006
Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic diseaseO David, A Grillo, B Ceoloni, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|April 20, 2013
The methodology of the Italian HBSC 2010 study (Health Behaviour in School-aged Children)G Lazzeri, M V Giacchi, P Dalmasso, et al.
The Journal of Hospital Infection|November 21, 2024
Antimicrobial efficacy of an experimental UV-C robot in controlled conditions and in a real hospital scenarioB Casini, M Scarpaci, F Chiovelli, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 25, 2017
Feasibility study on the assessment of auditory sustained attention through walking motor parameters in mild cognitive impairments and healthy subjectsL Fiorini, M Maselli, E Castro, et al.
Acta Diabetologica|March 29, 2011
A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetesM Trento, M Raballo, M Trevisan, et al.
Oncogene|April 17, 1997
Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblastsP Ciana, A Neri, C Cappellini, et al.
Journal of the National Cancer Institute|July 16, 1997
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12F Cavallo, P Signorelli, M Giovarelli, et al.
Pageof 20